Literature DB >> 35864261

Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers.

Marco Meloni1,2, Alfonso Bellia3,4, Laura Giurato3,4, Davide Lauro3,4, Luigi Uccioli5.   

Abstract

AIM: The aim of the current study is to evaluate the association between below-the-ankle (BTA) arterial disease and coronary artery disease (CAD) in patients with diabetic foot ulcers (DFUs).
METHODS: The study group was composed of patients with an active neuro-ischaemic DFUs managed in a tertiary care diabetic foot clinic. All patients received a pre-set limb salvage protocol including lower limb revascularization. By a retrospective analysis of individual angiograms, patients were divided in two groups: below-the-ankle (BTA) and above-the-ankle (ATA) arterial disease groups. The rate of CAD at baseline assessment and the new events of acute myocardial ischaemia (AMI) during 1-year of follow-up were evaluated and compared between the two groups.
RESULTS: Two hundreds seventy-two (272) patients were included, 120 (44.1%) showed BTA arterial disease while 152 (55.9%) ATA arterial disease. The mean age was 68.9 ± 9.6 years, 198 (72.8%) were male, 246 (90.4%) had type 2 diabetes, the mean diabetes duration was 20.7 ± 11.6 years, the mean HbA1c was 7.8 ± 4.2% (62 ± 22 mmmol/mol). The whole population reported CAD in 172 cases (63.4%), and the rate in the BTA group was significantly higher than in ATA group, respectively, 90 (75.4%) vs 82 (54.1%), p < 0.0001. During the follow-up, BTA group had 5% of new cases of AMI in comparison to 1.3% in ATA group (p < 0.001). At the multivariate analysis BTA resulted an independent marker of CAD [OR 1.9 CI 9 5% (1.3-4.5) p = 0.0001].
CONCLUSION: The current study shows a significant association between BTA arterial disease and CAD. A close cardiovascular screen should be required in patients with DFUs.
© 2022. Springer-Verlag Italia S.r.l., part of Springer Nature.

Entities:  

Keywords:  Below-the-ankle arterial disease; Coronary artery disease; Diabetes; Diabetic foot ulcers; Peripheral arterial disease

Mesh:

Year:  2022        PMID: 35864261     DOI: 10.1007/s00592-022-01932-w

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.087


  16 in total

1.  Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients.

Authors:  Jan Apelqvist; Targ Elgzyri; Jan Larsson; Magnus Löndahl; Per Nyberg; Johan Thörne
Journal:  J Vasc Surg       Date:  2011-04-23       Impact factor: 4.268

2.  Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.

Authors:  K G Smolderen; K Wang; G de Pouvourville; B Brüggenjürgen; J Röther; U Zeymer; K G Parhofer; P G Steg; D L Bhatt; E A Magnuson
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-10-15       Impact factor: 7.069

3.  One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  Kim G Smolderen; Alan Bell; Yang Lei; Eric A Cohen; P Gabriel Steg; Deepak L Bhatt; Elizabeth M Mahoney
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

4.  Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization.

Authors:  Amir H Sadrzadeh Rafie; Marcia L Stefanick; Stacy T Sims; Tiffany Phan; Mamie Higgins; Andre Gabriel; Themistocles Assimes; Balasubramanian Narasimhan; Kevin T Nead; Jonathan Myers; Jeffrey Olin; John P Cooke
Journal:  Vasc Med       Date:  2010-12       Impact factor: 3.239

5.  Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers.

Authors:  Marco Meloni; Valentina Izzo; Laura Giurato; Roberto Gandini; Luigi Uccioli
Journal:  Diabetes Res Clin Pract       Date:  2019-05-09       Impact factor: 5.602

6.  Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease.

Authors:  Aleš Blinc; Matija Kozak; Mišo Šabovič; Mojca Božič Mijovski; Mojca Stegnar; Pavel Poredoš; Andrej Kravos; Breda Barbič-Žagar; Janez Stare; Maja Pohar Perme
Journal:  Int Angiol       Date:  2016-06-22       Impact factor: 2.789

7.  Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.

Authors:  M A Gershater; M Löndahl; P Nyberg; J Larsson; J Thörne; M Eneroth; J Apelqvist
Journal:  Diabetologia       Date:  2008-11-27       Impact factor: 10.122

8.  Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study.

Authors:  L Prompers; M Huijberts; N Schaper; J Apelqvist; K Bakker; M Edmonds; P Holstein; E Jude; A Jirkovska; D Mauricio; A Piaggesi; H Reike; M Spraul; K Van Acker; S Van Baal; F Van Merode; L Uccioli; V Urbancic; G Ragnarson Tennvall
Journal:  Diabetologia       Date:  2008-07-22       Impact factor: 10.122

9.  Impact of diabetes type on treatment and outcome of patients with peripheral artery disease.

Authors:  Lars Richter; Eva Freisinger; Florian Lüders; Katrin Gebauer; Matthias Meyborg; Nasser M Malyar
Journal:  Diab Vasc Dis Res       Date:  2018-09-24       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.